Amini: The systemic landscape is constantly changing and is very exciting. It will only become more complicated for our ...
Amini: This requires communication from all team members, which we can typically do seamlessly now through the electronic medical record. Our medical oncologists typically take the lead but we all ...
Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...
In the U.S., FDA approval establishes Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) as the first immunotherapy combination approved for adult and pediatric patients 12 ...
Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but prescription stockpiles are limited.
Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.
Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...
It can feel like everything is a cancer risk these days, even items that used to be considered "good" for our overall health (we see you, red wine). However, it goes without saying that "cancer" is a ...
Vietnam Investment Review on MSN
Belief BioMed gains Macao approval for hemophilia B gene therapy
SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical ...
Everyday Health on MSN
Diagnosed with advanced renal cell carcinoma: Why you may want a second opinion, and how to find one
Since there are so many options available to treat advanced renal cell carcinoma, it may be helpful to seek out additional opinions about the best possible care.
Incyte (INCY) looks undervalued vs the 2028 Jakafi patent cliff; see why non-Jakafi growth and pipeline optionality could ...
Combining Trinity's high yield and Bristol Myers' defensive dividend growth can enhance both income and total return for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results